On May 24, 2023 NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotechnology company developing Stealth Editors to perform in vivo gene editing without triggering the immune system, reported that the Company’s management will participate in the Jefferies Healthcare Conference being held at the Marriott Marquis in New York, NY on June 7-9, 2023 (Press release, NeuBase Therapeutics, MAY 24, 2023, View Source [SID1234631999]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation Details for the Jefferies Healthcare Conference
Company NeuBase Therapeutics
Date: Friday, June 9, 2023
Time: 8:00 a.m. ET
Room: Track 1
Format: Corporate Presentation
A live webcast of the Company’s presentation will be available at View Source and the investor relations section of the Company’s website at click here. A replay of the Company’s presentation will be available for 90 days on the Company’s website following the event at click here.
Please contact your representative at Jefferies to schedule a one-on-one meeting with NeuBase management during the conference.